Basic experiments with clotrimazole administered orally
- PMID: 340135
- DOI: 10.1185/03007997709110160
Basic experiments with clotrimazole administered orally
Abstract
A series of experiments was carried out with the antimycotic agent clotrimazole to establish MICs against a number of different yeasts and to estimate its blood levels following oral administration. Marked differences were noted between the MIC against A and B serotypes of Candida albicans in its yeast-like cell form, that against Type B being nearly 10-times higher than against Type A. Against the mycelial form, however, the MIC was much lower and there was little difference between the levels for the two serotypes. Clotrimazole administered in oral tablet form appeared to be poorly absorbed, little being transferred to the blood. Urinary levels were low and large amounts of the drug were detected in the faeces. Serum levels were below MIC levels in all cases examined. Blood levels 3-times as great as those after the same dosage in tablet form were produced when clotrimazole was given in oil solution and even with 250 mg, effective blood levels were achieved and maintained.
Similar articles
-
Chronic mucocutaneous candidiasis. Successful treatment with intermittent oral doses of clotrimazole.Arch Dermatol. 1979 Mar;115(3):322-3. doi: 10.1001/archderm.115.3.322. Arch Dermatol. 1979. PMID: 434848
-
Vulvovaginal candidiasis in pregnancy treated with clotrimazole.Acta Obstet Gynecol Scand. 1978;57(5):453-5. doi: 10.3109/00016347809156527. Acta Obstet Gynecol Scand. 1978. PMID: 364918 Clinical Trial.
-
Experimental in vitro and in vivo comparison of modern antimycotics.Curr Med Res Opin. 1977-1978;5(4):315-27. doi: 10.1185/03007997709110187. Curr Med Res Opin. 1977. PMID: 630908
-
Clotrimazole: intermittent therapy in chronic mucocutaneous candidiasis.Am J Dis Child. 1977 Mar;131(3):305-7. doi: 10.1001/archpedi.1977.02120160059009. Am J Dis Child. 1977. PMID: 842517
-
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.Drugs. 1975;9(6):424-47. doi: 10.2165/00003495-197509060-00003. Drugs. 1975. PMID: 1097234 Review.
Cited by
-
Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum.Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):331-6. doi: 10.1073/pnas.97.1.331. Proc Natl Acad Sci U S A. 2000. PMID: 10618418 Free PMC article.
-
Clotrimazole troches can alter everolimus pharmacokinetics in post-transplant patients: A case report.Br J Clin Pharmacol. 2019 Sep;85(9):2176-2178. doi: 10.1111/bcp.14017. Epub 2019 Jun 26. Br J Clin Pharmacol. 2019. PMID: 31243774 Free PMC article. No abstract available.
-
Drug interactions between tacrolimus and clotrimazole troche: a data mining approach followed by a pharmacokinetic study.Eur J Clin Pharmacol. 2020 Jan;76(1):117-125. doi: 10.1007/s00228-019-02770-6. Epub 2019 Oct 26. Eur J Clin Pharmacol. 2020. PMID: 31654150
-
Clotrimazole induces a late G1 cell cycle arrest and sensitizes glioblastoma cells to radiation in vitro.Anticancer Drugs. 2010 Oct;21(9):841-9. doi: 10.1097/CAD.0b013e32833e8022. Anticancer Drugs. 2010. PMID: 20724915 Free PMC article.
-
Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients.Transpl Infect Dis. 2022 Aug;24(4):e13882. doi: 10.1111/tid.13882. Epub 2022 Jun 17. Transpl Infect Dis. 2022. PMID: 35689488 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources